NICE Methodology Raises Concerns For Kidney Research UK
The National Institute for Health and Care Excellence's (NICE) draught guidance on medicines for COVID-19 patients has received a response...
As Per The WHO Assessment, AMR Monitoring Must Be Enhanced
Common bacterial illnesses are getting more and more resistant to treatments, according to the World Health Organization's (WHO) Global Antimicrobial...
Market For Oligonucleotides Forecast To Hit $16.7bn By 2027
The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology is expected to cause the...
India Keen To Establish National Database On Dosage Forms
In an effort to better inform and empower consumers, the Indian government has announced plans to create a comprehensive database...
New Decoy Medication Neutralises COVID-19 And Variations
Dana-Farber scientists have developed a medication that neutralises SARS-CoV-2, the COVID-19 coronavirus, and every other tested version. The medicine is...
Pharma Alliance Worth $5 Billion In Bispecific Antibodies
Ivonescimab (PD-1/VEGF, AK112), a ground-breaking bispecific antibody, will be out-licensed by Biopharma Akeso Inc. to Summit Therapeutics Inc. for use...
Addressing Cholestatic Liver Disease Upon Cognitive Decline
Cholestatic Bile flow can be hampered by liver conditions like primary biliary cholangitis (PBC), which can result in neurological problems....
Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operation
Fraunhofer IZI, one of Europe’s leading manufacturers of cell and gene therapies for clinical trials, intends to digitalize its manufacturing...
Could The New 3D Substances Enhance The Delivery of Drugs?
In order to provide effective, extended-release medication delivery, Japanese researchers have developed TUS-84, a new three-dimensional (3D) covalent organic framework...
Q3 Market Capitalization Declines For Top Biopharma Firms
The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.